Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 GBX | +7.69% | +7.69% | -12.50% |
Jun. 07 | Physiomics wins "significant" GBP160,000 contract | AN |
Jun. 07 | Physiomics Secures Virtual Tumor Technology Deal With UK Biotech Company | MT |
Sales 2024 * | 625K 795K | Sales 2025 * | - | Capitalization | 1.9M 2.41M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - | EV / Sales 2024 * | 2.75 x |
Net cash position 2024 * | 180K 229K | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.11
x | P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.74% |
Latest transcript on Physiomics Plc
1 day | +7.69% | ||
1 week | +7.69% | ||
Current month | +7.69% | ||
1 month | +7.69% | ||
6 months | -9.68% | ||
Current year | -12.50% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Sargent
CEO | Chief Executive Officer | - | 23-09-04 |
Jim Millen
CHM | Chairman | 55 | 16-04-17 |
Director of Finance/CFO | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Corn
BRD | Director/Board Member | 73 | 22-03-31 |
Shalabh Kumar
BRD | Director/Board Member | - | 22-08-31 |
Jim Millen
CHM | Chairman | 55 | 16-04-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.4 | +7.69% | 2,815,823 |
24-06-06 | 1.3 | 0.00% | 3,706 |
24-06-05 | 1.3 | 0.00% | 28,151 |
24-06-04 | 1.3 | 0.00% | 3,000 |
24-06-03 | 1.3 | 0.00% | 65,622 |
Delayed Quote London S.E., June 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.50% | 2.41M | |
-2.67% | 134B | |
+21.33% | 77B | |
-13.08% | 38.95B | |
+16.20% | 38.52B | |
-5.67% | 28.84B | |
+3.78% | 13.85B | |
+11.32% | 10.58B | |
-18.80% | 4.21B | |
-38.55% | 3.8B |
- Stock Market
- Equities
- PYC Stock